 |
|
Risk of Dementia Among White and African American Relatives of Patients With Alzheimer Disease
Robert C. Green, MD,MPH;
L. Adrienne Cupples, PhD;
Rodney Go, PhD;
Kelly S. Benke, AB;
Timi Edeki, MD,PhD;
Patrick A. Griffith, MD;
Mary Williams, EdD,PAC;
Yvonne Hipps, PhD;
Neill Graff-Radford, MD;
David Bachman, MD;
Lindsay A. Farrer, PhD;
for the MIRAGE Study Group
JAMA. 2002;287:329-336.
Context Evidence exists that the incidence of Alzheimer disease (AD), as well as risk attributable to specific genetic factors such as apolipoprotein E (APOE) genotype, may vary considerably among ethnic groups. Family studies of probands with AD offer an opportunity to evaluate lifetime risk of dementia among relatives of these probands.
Objective To compare lifetime dementia risk estimates among relatives of white and African American probands with probable or definite AD.
Design and Setting Risk analysis using data collected by questionnaire and supplemental records between May 1991 and March 2001 at 17 medical centers contributing to the Multi-Institutional Research in Alzheimer's Genetic Epidemiology Study.
Participants A total of 17 639 first-degree biological relatives and 2474 spouses of 2339 white AD probands, and 2281 first-degree biological relatives and 257 spouses of 255 African American AD probands.
Main Outcome Measures Cumulative risk of dementia by age 85 years, stratified by ethnicity and sex of relatives and by APOE genotype of probands.
Results Cumulative risk of dementia in first-degree biological relatives of African American AD probands by age 85 years was 43.7% (SE, 3.1%), and the corresponding risk in first-degree biological relatives of white AD probands was 26.9% (SE, 0.8%), yielding a relative risk (RR) of 1.6 (95% confidence interval [CI], 1.4-1.9; P<.001). The risk in spouses of African American AD probands of 18.5% (SE, 8.4%) was also higher than the risk in white spouses of 10.4% (SE, 1.7%) but did not reach statistical significance (RR, 1.8; 95% CI, 0.5-6.0; P = .34), likely due to the smaller sample size of African Americans. The proportional increase in risk of dementia among white first-degree biological relatives compared with white spouses of 2.6 (95% CI, 2.1-3.2) was similar to that of 2.4 (95% CI, 1.3-4.4) in African American first-degree biological relatives compared with African American spouses. Female first-degree biological relatives of probands had a higher risk of developing dementia than did their male counterparts, among whites (31.2% vs 20.4%; RR, 1.5; 95% CI, 1.3-1.7; P<.001) as well as among African Americans, although this was not significant among African Americans (46.7% vs 40.1%; RR, 1.2; 95% CI, 0.9-1.7, P = .30). The patterns of risk among first-degree biological relatives stratified by APOE genotype of the probands were similar in white families and African American families.
Conclusion First-degree relatives of African Americans with AD have a higher cumulative risk of dementia than do those of whites with AD. However, in this study, the additional risk of dementia conferred by being a first-degree relative, by being female, or by the probability of having an APOE  4 allele appeared similar in African American and white families. These data provide estimates of dementia risk that can be used to offer counseling to family members of patients with AD.
Author Affiliations: Genetics Program and Department of Neurology, Department of Medicine, School of Medicine (Drs Green and Farrer and Ms Benke) and Department of Epidemiology and Biostatistics, School of Public Health (Drs Cupples and Farrer), Boston University, Boston, Mass; Department of Epidemiology, University of Alabama School of Public Health, Birmingham (Dr Go); Departments of Medicine and Pharmacology, Morehouse School of Medicine, Atlanta, Ga (Drs Edeki, Griffith, Williams, and Hipps); Department of Neurology, Mayo Clinic, Jacksonville, Fla (Dr Graff-Radford); and Department of Psychiatry, Medical University of South Carolina, Charleston (Dr Bachman).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease
Mosconi et al.
Neurology 2009;72:513-520.
ABSTRACT
| FULL TEXT
Association of Distinct Variants in SORL1 With Cerebrovascular and Neurodegenerative Changes Related to Alzheimer Disease
T. Cuenco et al.
Arch Neurol 2008;65:1640-1648.
ABSTRACT
| FULL TEXT
From the Cover: Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism
Mosconi et al.
Proc. Natl. Acad. Sci. USA 2007;104:19067-19072.
ABSTRACT
| FULL TEXT
Effect of Alzheimer Disease Risk on Brain Function During Self-appraisal in Healthy Middle-aged Adults
Johnson et al.
Arch Gen Psychiatry 2007;64:1163-1171.
ABSTRACT
| FULL TEXT
Primary prevention trials in Alzheimer disease.
Green and DeKosky
Neurology 2006;67:S2-S5.
ABSTRACT
| FULL TEXT
Prevention trials in Alzheimer disease: One step forward?
Touchon et al.
Neurology 2006;67:S21-S22.
ABSTRACT
| FULL TEXT
Predictors of Subjective Memory Complaint in Cognitively Normal Relatives of Patients with Alzheimer's Disease
Tsai et al.
J. Neuropsychiatry Clin. Neurosi. 2006;18:384-388.
ABSTRACT
| FULL TEXT
When it runs in the family: putting susceptibility genes in perspective
Lock et al.
Public Understanding of Science 2006;15:277-300.
ABSTRACT
The influence of Alzheimer disease family history and apolipoprotein E epsilon4 on mesial temporal lobe activation.
Johnson et al.
J. Neurosci. 2006;26:6069-6076.
ABSTRACT
| FULL TEXT
Association of apolipoprotein e genotype and Alzheimer disease in african americans.
Murrell et al.
Arch Neurol 2006;63:431-434.
ABSTRACT
| FULL TEXT
Genetic Risk Assessment for Adult Children of People With Alzheimer's Disease: The Risk Evaluation and Education for Alzheimer's Disease (REVEAL) Study
Roberts et al.
J Geriatr Psychiatry Neurol 2005;18:250-255.
ABSTRACT
Black-White Disparities in Functional Decline in Older Persons: The Role of Cognitive Function
Moody-Ayers et al.
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2005;60:933-939.
ABSTRACT
| FULL TEXT
Genetic Testing For Alzheimer's Disease And Its Impact On Insurance Purchasing Behavior
Zick et al.
Health Aff (Millwood) 2005;24:483-490.
ABSTRACT
| FULL TEXT
Brain Cholesterol: Long Secret Life Behind a Barrier
Bjorkhem and Meaney
Arterioscler. Thromb. Vasc. Bio. 2004;24:806-815.
ABSTRACT
| FULL TEXT
Essentials of the Proper Diagnoses of Mild Cognitive Impairment, Dementia, and Major Subtypes of Dementia
Knopman et al.
Mayo Clin Proc. 2003;78:1290-1308.
ABSTRACT
Depression as a Risk Factor for Alzheimer Disease: The MIRAGE Study
Green et al.
Arch Neurol 2003;60:753-759.
ABSTRACT
| FULL TEXT
Prospective Study of Alcohol Consumption and Risk of Dementia in Older Adults
Mukamal et al.
JAMA 2003;289:1405-1413.
ABSTRACT
| FULL TEXT
Apolipoprotein E, Alzheimer Disease, and African Americans
Mayeux
Arch Neurol 2003;60:161-163.
FULL TEXT
To test or not to test: Interest in genetic testing for Alzheimer's disease among middle-aged adults
Cutler and Hodgson
AM J ALZHEIMERS DIS OTHER DEMEN 2003;18:9-20.
ABSTRACT
Association Between Apolipoprotein E Genotype and Alzheimer Disease in African American Subjects
Graff-Radford et al.
Arch Neurol 2002;59:594-600.
ABSTRACT
| FULL TEXT
|
